Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clomipramine-induced urinary dysfunction in an obsessive-compulsive adolescent.

H Hermesh1, D Aizenberg, A Weizman

  • 1Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Israel.

Drug Intelligence & Clinical Pharmacy
|November 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insight into the current practice of ototoxicity monitoring during cisplatin therapy.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2021
Same author

Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study.

Schizophrenia research·2020
Same author

The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.

European psychiatry : the journal of the Association of European Psychiatrists·2018
Same author

The Effectiveness of a Knowledge Translation Cognitive-Educational Intervention for Family Members of Persons Coping with Severe Mental Illness.

Community mental health journal·2017
Same author

CD44 Deficiency Is Associated with Increased Susceptibility to Stress-Induced Anxiety-like Behavior in Mice.

Journal of molecular neuroscience : MN·2016
Same author

Quinazoline-based tricyclic compounds that regulate programmed cell death, induce neuronal differentiation, and are curative in animal models for excitotoxicity and hereditary brain disease.

Cell death discovery·2016

Clomipramine, used for obsessive-compulsive disorder, can cause urinary retention in adolescents. This side effect, linked to dosage, may involve noncholinergic and nonadrenergic pathways, necessitating drug discontinuation.

Area of Science:

  • Pharmacology
  • Adverse Drug Reactions
  • Adolescent Medicine

Background:

  • Obsessive-compulsive disorder (OCD) is a mental health condition often treated with selective serotonin reuptake inhibitors (SSRIs).
  • Clomipramine is a tricyclic antidepressant (TCA) with SSRI properties, effective for OCD but associated with various side effects.
  • Urinary retention is a known, albeit less common, anticholinergic side effect of TCAs.

Observation:

  • A 15-year-old male experienced two episodes of urinary retention after starting clomipramine for OCD.
  • Both the therapeutic effects and side effects of clomipramine, including urinary retention, were dose-dependent.
  • The severity of the urinary retention was significant, showing resistance to treatments like bethanechol and phenoxybenzamine.

Findings:

Related Experiment Videos

  • This case highlights that clomipramine-induced urinary retention can occur in adolescents, not exclusively in older populations.
  • The adverse drug reaction necessitated complete cessation of clomipramine treatment.
  • The resistance to standard pharmacological interventions suggests potential noncholinergic and nonadrenergic mechanisms contributing to the retention.

Implications:

  • Clinicians should be vigilant for urinary retention as a potential side effect of clomipramine in adolescent patients.
  • Dosage adjustments and careful monitoring are crucial when prescribing clomipramine to younger individuals.
  • Further research may be warranted to elucidate the specific noncholinergic and nonadrenergic pathways involved in clomipramine-induced urinary retention.